JPWO2021007277A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021007277A5 JPWO2021007277A5 JP2022500582A JP2022500582A JPWO2021007277A5 JP WO2021007277 A5 JPWO2021007277 A5 JP WO2021007277A5 JP 2022500582 A JP2022500582 A JP 2022500582A JP 2022500582 A JP2022500582 A JP 2022500582A JP WO2021007277 A5 JPWO2021007277 A5 JP WO2021007277A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- linker
- agonist
- formula
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962871686P | 2019-07-08 | 2019-07-08 | |
| US62/871,686 | 2019-07-08 | ||
| US201962872146P | 2019-07-09 | 2019-07-09 | |
| US62/872,146 | 2019-07-09 | ||
| PCT/US2020/041120 WO2021007277A1 (en) | 2019-07-08 | 2020-07-08 | Compounds and methods for the treatment and prevention of fibrotic disease states and cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539804A JP2022539804A (ja) | 2022-09-13 |
| JPWO2021007277A5 true JPWO2021007277A5 (https=) | 2023-07-14 |
| JP2022539804A5 JP2022539804A5 (https=) | 2023-07-14 |
Family
ID=74114231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500582A Pending JP2022539804A (ja) | 2019-07-08 | 2020-07-08 | 線維性疾患状態およびがんの治療および予防のための化合物ならびに方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12397059B2 (https=) |
| EP (1) | EP3996715A4 (https=) |
| JP (1) | JP2022539804A (https=) |
| CN (2) | CN114269346A (https=) |
| AU (1) | AU2020310141A1 (https=) |
| CA (1) | CA3145908A1 (https=) |
| WO (1) | WO2021007277A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022271866A1 (en) * | 2021-05-14 | 2023-12-07 | Purdue Research Foundation | Folate receptor-targeted conjugates with brush border membrane enzyme-cleavable linkers and methods of use in imaging and treating cancer |
| CN116947658B (zh) * | 2023-07-28 | 2025-10-28 | 南通华祥医药科技有限公司 | 一种1-氨基-2-甲基-2-丙醇的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060142202A1 (en) * | 2000-12-08 | 2006-06-29 | 3M Innovative Properties Company | Compositions and methods for targeted delivery of immune response modifiers |
| KR20040053136A (ko) * | 2001-09-28 | 2004-06-23 | 펄듀 리서치 파운데이션 | 리간드-면역원 공액체를 이용한 치료 방법 |
| WO2007093901A1 (en) * | 2006-02-17 | 2007-08-23 | Pfizer Limited | 3 -deazapurine derivatives as tlr7 modulators |
| AR065784A1 (es) | 2007-03-20 | 2009-07-01 | Dainippon Sumitomo Pharma Co | Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas. |
| CN112587671A (zh) * | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| US20170266303A1 (en) | 2014-11-25 | 2017-09-21 | Endocyte, Inc. | Methods of treating cancer by targeting tumor-associated macrophages |
| WO2017205661A1 (en) * | 2016-05-25 | 2017-11-30 | Purdue Research Foundation | Method of treating cancer by targeting myeloid-derived suppressor cells |
| CN115916342A (zh) * | 2020-07-08 | 2023-04-04 | 普渡研究基金会 | 用于治疗纤维化疾病和癌症的化合物、组合物和方法 |
-
2020
- 2020-07-08 CA CA3145908A patent/CA3145908A1/en active Pending
- 2020-07-08 US US17/625,461 patent/US12397059B2/en active Active
- 2020-07-08 CN CN202080058464.1A patent/CN114269346A/zh active Pending
- 2020-07-08 JP JP2022500582A patent/JP2022539804A/ja active Pending
- 2020-07-08 WO PCT/US2020/041120 patent/WO2021007277A1/en not_active Ceased
- 2020-07-08 CN CN202510532845.3A patent/CN120381528A/zh active Pending
- 2020-07-08 EP EP20836085.9A patent/EP3996715A4/en active Pending
- 2020-07-08 AU AU2020310141A patent/AU2020310141A1/en active Pending
-
2025
- 2025-07-09 US US19/264,776 patent/US20250352652A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8609706B2 (en) | Compounds and methods for inhibiting the interaction of BCL proteins with binding partners | |
| CN101843897B (zh) | 治疗脱髓鞘疾病的鞘氨醇-1-磷酸受体激动剂 | |
| JP2004517049A5 (https=) | ||
| DK2326329T3 (en) | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine | |
| JP2019503365A5 (https=) | ||
| JP2006523216A5 (https=) | ||
| RU2010126063A (ru) | Производные 4-(2-амино-1-гидроксиэтил)фенола как агонисты в2 адренергического рецептора | |
| TW201808345A (zh) | 聚乙二醇化卡非佐米化合物 | |
| US11844780B2 (en) | Chlorinated tetralin compounds and pharmaceutical compositions | |
| JP2006523214A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| JP2006508965A5 (https=) | ||
| RU2002130247A (ru) | Производные оксадиазола, обладающие противоопухолевым действием | |
| JP2025118775A5 (https=) | ||
| JPWO2021093839A5 (https=) | ||
| JPWO2021007277A5 (https=) | ||
| CA2635093A1 (en) | Derivatives of sulindac, use thereof and preparation thereof | |
| RU2007105582A (ru) | Агонисты рецепторов никотина и способы их применения для лечения воспалительных заболеваний | |
| US8642580B2 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives | |
| JP2008519763A5 (https=) | ||
| JP2019525924A5 (https=) | ||
| US20160143914A1 (en) | Nanoparticles for Encapsulation and Delivery of Bioactive Compounds and Compositions Thereof | |
| JP2007519701A5 (https=) | ||
| EP4706656A1 (en) | Combination therapy of dacomitinib and nintedanib for prevention or treatment of pulmonary fibrosis | |
| CN121419775A (zh) | 用于预防或治疗肺纤维化的培西达替尼和尼达尼布的联合疗法 |